Target Validation, Boston, MA, USA
Event Nov 11
Early validation and invalidation approaches continue to improve to allow researchers to make the most informed choice early and advance that chosen target toward the clinic for final evaluation. In vivo validation using RNAi, imaging and other techniques will receive focused attention at this meeting along with an in-depth analysis of the target validation decision process. Ample time for networking and facilitated discussion with conference participants from biotech and the pharmaceutical industry will be a signature feature of this event.